News

หนุ่มจบชีวิตตัวเอง หลังทำงานร้านสะดวกซื้อ 6 เดือนติด ไม่ได้หยุดแม้แต่วันเดียว

- by Admin - 45 Comments.

เว็บไซต์ asahi รายงานข่าว ทางการญี่ปุ่นรับรองว่า การเสียชีวิตของผู้จัดการร้าน 7-Eleven วัย 38 ปี ในจังหวัดโออิตะ เป็นอุบัติเหตุจากการทำงาน หลังพบว่าเขาทำงานต่อเนื่อง 6 เดือนโดยไม่มีวันหยุด ก่อนฆ่าตัวตายในเดือนกรกฎาคม 2022

ในจดหมายลาตาย เขาระบุว่า “การทำงานหนักโดยไม่มีวันพักกลายเป็นเรื่องปกติ” และ “การเป็นผู้จัดการร้านสะดวกซื้อก็เหมือนการถูกเอาเปรียบ”

สำนักงานแรงงานพบว่า เขาทำงานแทบตลอดเวลา ต้องคอยรับโทรศัพท์แม้กลับถึงบ้าน และนอนวันละเพียง 2 ชั่วโมง โดยไม่มีวันหยุดแม้แต่วันเดียวในช่วง 6 เดือนก่อนเสียชีวิต

แม้จะเป็นพนักงานของเจ้าของแฟรนไชส์ แต่ข้อมูลเวลางานถูกส่งถึงสำนักงานใหญ่ของ 7-Eleven ญี่ปุ่น ทำให้ครอบครัวเรียกร้องให้บริษัทแม่ร่วมรับผิดชอบ

ด้านสำนักงานใหญ่ปฏิเสธความรับผิดชอบ โดยชี้ว่าการจ้างงานเป็นหน้าที่ของเจ้าของร้าน ไม่ใช่บริษัท

กรณีนี้สะท้อนปัญหาสภาพการทำงานหนักในร้านสะดวกซื้อญี่ปุ่น ซึ่งเคยมีรายงานผู้เสียชีวิตจากการทำงานหนักมาแล้วหลายครั้ง

Related Posts

“แผ่นดินไหว” 8 ต.ค. 68 ไทยใกล้ศูนย์กลาง ทั่วโลกรหัสแดง สะเทือนมาก 6.6

พยากรณ์อากาศวันนี้ 8 ต.ค. 68 ร่องมรสุมพาดผ่าน ไทยฝนเพิ่มขึ้น

อัปเดตราคาทองคำ วันนี้ 8 ต.ค. 68 ปรับตัวขึ้นพรวดเดียว 500 บาท เช็กราคาทองรูปพรรณ ราคาทอง 1 สลึงวันนี้ อยู่ที่เท่าไหร่

About Admin

View all posts by Admin →

45 Comments on “หนุ่มจบชีวิตตัวเอง หลังทำงานร้านสะดวกซื้อ 6 เดือนติด ไม่ได้หยุดแม้แต่วันเดียว”

  28. Anavar is a popular anabolic steroid known for
    its mild nature and ability to help users maintain lean muscle mass while minimizing water retention. Many athletes and bodybuilders
    incorporate it into a testosterone (Test) cycle, especially when they want to keep
    the strength gains from Test without adding bulk or swelling.
    A typical 6‑week Anavar phase can be stacked with Test to produce impressive results, but timing, dosage, and post-cycle care are crucial for optimal outcomes.

    Anavar and Test Cycle – Before & After

    Before the cycle, most users are already on a stable dose of testosterone, usually ranging from
    300 to 500 mg per week. This baseline ensures that their endocrine system is primed for anabolic activity.
    The introduction of Anavar typically occurs after the first two
    weeks of Test to give the body time to adapt. A common 6‑week schedule looks like this:

    Week 1–2: 200 mg of Test weekly (about 28 mg per day).

    Week 3–4: Add 20 mg of Anavar daily, continuing with Test
    at 200 mg weekly.

    Week 5–6: Increase Anavar to 30 mg daily while maintaining the Test dose.

    The before state often involves visible muscle mass from
    prior training but can be marred by water retention or a lack of definition. After six weeks, many users report tighter, more shredded physiques
    with an increased rate of strength gains. The combination helps preserve lean tissue that might otherwise be lost during
    heavy cutting phases.

    Results

    Lean Muscle Preservation – Anavar’s selective androgen receptor binding keeps muscle protein synthesis high while preventing the conversion to estrogen, so water retention is minimal.
    When stacked with Test, users can maintain or even increase muscle mass despite calorie deficits.

    Strength Gains – Testosterone provides the bulk of strength potential; adding Anavar amplifies this by increasing
    nitrogen retention and enhancing glycogen storage in muscles.
    A 6‑week cycle often yields an additional 5–10% lift improvement over Test alone.

    Fat Loss & Definition – The steroid’s ability to boost metabolism
    helps burn stored fat. Combined with a well‑structured diet, users can see a clearer separation of muscle groups and more vascularity.

    Recovery – Users typically experience faster
    recovery between workouts due to improved protein synthesis and reduced inflammation.

    Anavar and Test: What’s the Difference?

    While both compounds are anabolic steroids, their mechanisms differ:

    Testosterone is the primary male sex hormone that drives overall anabolism,
    libido, bone density, and red blood cell production. It has
    a strong estrogenic conversion (via aromatase), which can cause water retention or gynecomastia if not managed.

    Anavar (Oxandrolone) is a synthetic derivative of DHT that selectively binds to androgen receptors in muscle and bone.

    It has minimal aromatization, meaning it rarely causes estrogen‑related side effects.
    Its primary benefit lies in promoting lean mass growth with low water retention, making it ideal
    for cutting phases or preserving gains during caloric deficits.

    Because Anavar does not stimulate the pituitary gland as strongly as Test, stacking
    them allows users to keep a robust anabolic drive (from Test) while using Anavar’s mild, focused muscle‑building
    properties. This synergy reduces the risk of estrogenic side effects that can accompany high doses of testosterone alone.

    Anavar Dosage

    The dosage for a 6‑week cycle is typically lower than many
    other steroids because Anavar is potent and can produce significant gains even at modest amounts.
    A standard regimen might be:

    Daily Dose – 20–30 mg per day.

    Weekly Split – If the user prefers, they can take 140–210 mg weekly
    divided into two or three doses (e.g., 70 mg twice a week).

    Duration – Keep the cycle at six weeks; extending
    beyond eight weeks increases the risk of liver strain and
    other adverse effects.

    When stacking with Test:

    Start with a stable Test dose of 200–300 mg per week.

    Add Anavar after two weeks to avoid overwhelming the body.

    Increase Anavar to 30 mg daily only if your health markers (liver enzymes, cholesterol) remain within normal ranges.

    Post‑Cycle Care

    After six weeks, users should consider a post-cycle therapy (PCT) program because both Test and Anavar
    suppress natural testosterone production. A typical PCT might include:

    Sermorelin or Clomid – 50 mg twice daily for two weeks to kickstart endogenous
    hormone production.

    Liver Support Supplements – Milk thistle, N‑acetylcysteine, and glutathione help mitigate any hepatic stress from Anavar.

    Diet & Training – Continue a protein‑rich diet
    and moderate resistance training to preserve the gains made
    during the cycle.

    In summary, a 6‑week Anavar and Test stack can deliver significant lean muscle
    retention, strength improvements, and fat loss while keeping water retention low.
    By carefully timing the introduction of Anavar, maintaining a
    moderate dose, and following proper PCT protocols, users can maximize benefits and
    minimize risks.

  34. Ipamorelin acetate is a synthetic growth hormone releasing peptide that has
    gained popularity among athletes and bodybuilders for its ability to stimulate natural growth
    hormone production without the aggressive side effects associated with some other analogues.
    While it is generally considered safe when used as directed, users should be aware of potential adverse reactions that can arise from improper
    dosing, contamination, or individual sensitivity. In addition to discussing
    ipamorelin acetate specifically, it is helpful to understand
    the broader context of growth hormone releasing peptides such as CJC‑1295, which shares some pharmacological
    characteristics and side effect profile.

    CJC 1295 Side Effects: What You Need to Know

    The peptide CJC‑1295 is a long‑acting growth hormone secretagogue that works
    by binding to somatostatin receptors and prolonging the release of growth hormone.
    Users have reported several side effects, including local injection site reactions such as pain, swelling,
    or bruising. Systemic symptoms can involve increased appetite, water retention leading to edema, headaches, dizziness,
    and tingling sensations in the extremities (paresthesia).
    More rarely, individuals experience elevated blood sugar levels
    or insulin resistance, which may exacerbate pre‑existing metabolic conditions.
    Because CJC‑1295 is often combined with other
    peptides like ipamorelin, these effects can be amplified.

    Introduction to CJC 1295 Side Effects

    When first introduced into the market, CJC‑1295 was noted for its potent ability to raise growth hormone levels over an extended
    period. Early clinical trials highlighted mild side effects such as injection site irritation and transient fatigue.
    Over time, anecdotal reports from athletes have expanded the list of potential adverse events.
    These include mild gastrointestinal discomfort, increased thirst, and in some cases a feeling of heaviness
    or sluggishness. Long‑term safety data remain limited; therefore, caution is advised for individuals with cardiovascular risk factors or
    endocrine disorders.

    Understanding CJC 1295

    CJC‑1295 functions by mimicking the natural hormone ghrelin,
    thereby stimulating growth hormone release through the hypothalamic–pituitary axis.

    Its structure allows it to resist degradation in the bloodstream, resulting in a
    longer duration of action compared to shorter peptides like ipamorelin. This extended half‑life can lead to
    more pronounced fluctuations in hormonal levels, which may
    manifest as mood swings or changes in sleep patterns.

    The peptide’s influence on insulin-like growth factor 1
    (IGF‑1) also has implications for tissue repair and metabolism, making side effect monitoring essential.

    Ipamorelin Acetate Side Effects

    When discussing ipamorelin acetate, it is important to differentiate between the compound itself
    and its role as a co‑administered agent with CJC‑1295.
    Common local reactions at injection sites include pain, redness, swelling, or a lump forming around the needle track.

    Systemic side effects are generally milder than those seen with other growth hormone secretagogues but
    can still occur. Users may notice increased appetite, especially after
    evening doses, which can contribute to weight gain if caloric intake is not adjusted.
    Some individuals report mild headaches, dizziness, or a feeling of fullness in the chest area.

    Less frequent adverse events involve fluid retention, leading
    to swelling in the ankles or feet, and transient fatigue or
    lethargy as the body adjusts to elevated growth hormone levels.
    Because ipamorelin can influence insulin secretion indirectly through IGF‑1 modulation, blood glucose
    monitoring is recommended for people with diabetes or prediabetes.
    Rarely, users have experienced changes in menstrual cycles or libido, likely reflecting hormonal shifts.

    Combination Effects and Overlap

    When ipamorelin acetate is used alongside CJC‑1295, the side effect profile can become more
    pronounced due to synergistic stimulation of growth hormone release.

    This may amplify fluid retention, elevate IGF‑1 levels beyond desired thresholds, and increase the risk of metabolic disturbances such as hyperglycemia
    or dyslipidemia. The cumulative burden on the cardiovascular system should also be considered, especially in individuals with
    hypertension or heart disease.

    Mitigation Strategies

    To reduce the likelihood of adverse reactions,
    it is advisable to start with low doses and gradually titrate upward while monitoring
    for symptoms. Maintaining proper injection technique—cleaning the site, rotating locations, and using a fresh needle—helps minimize local irritation. Staying hydrated and paying attention to dietary intake can counteract some
    appetite‑related side effects. Regular blood work assessing growth hormone, IGF‑1, insulin, glucose, and
    lipid panels provides objective data on how the body is responding.

    Long‑Term Considerations

    While short‑term use of ipamorelin acetate has shown limited serious
    adverse events, long‑term safety remains under investigation. Chronic elevation of growth hormone can potentially increase the
    risk of certain cancers or exacerbate conditions such as
    osteoarthritis due to cartilage turnover changes. Therefore, individuals should consider
    periodic medical evaluations and discuss any new symptoms promptly with
    a qualified healthcare provider.

    In summary, ipamorelin acetate offers a relatively favorable side effect
    profile compared to other peptides, but users must remain vigilant for
    local injection reactions, fluid retention, appetite changes, and metabolic disturbances.

    When combined with CJC‑1295, the risk of overlapping
    adverse events rises, necessitating careful dosing, monitoring, and professional guidance to ensure safety and efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *